The objective of this ambitious project is to develop an artificial placenta for extreme premature babies, which will allow the fetus to be kept out of the womb in an environment as similar as possible to it and thus minimize the risk of sequelae.

Start: 2020

“The development of the artificial placenta will change the course of medicine”

Innovation & Impact

The artificial placenta will significantly decrease complications from extreme prematurity (and other fetal conditions), increasing survival and reducing morbidity associated with extreme prematurity. Furthermore, in a more advanced phase, it would make possible interventions on the fetus in malformations or serious illnesses. Currently, it is estimated that up to 25,000 fetuses annually in Europe suffer serious problems that could be operated if there were no difficulties in accessing the fetus.


Eduard Gratacós
Project’s director

Elisenda Eixarch
Senior Investigator

Miriam Illa
Senior Fetal Medicine Coordinator

Fàtima Crispi

Ameth Hawkins

 Vasili Sircheli
Laboratory technician

Elisenda Bonet
Scientific Manager

Aleix García
Research Manager


  • Unitat de Perfusió de l’Hospital Clínic: Maite Mata, Marina Chorda, Mireia Gispert, Víctor Gómez
  • UAB: Diana Marre
  • IBEC: Josep Samitier, María J López-Martínez
  • IQS: Salvador Borrós, Núria Agulló, Guillermo Reyes
  • UPC: Ferran Marqués, Verónica Vilaplana


Powered by

With the collaboration of

web obra social la caixa
web cerebra
Web proyecto cellex
Web link ciberer
Web link hernia diagrafmática congénita
Ministerio de economía web link
Red SAMID web link
fondos feder web link
Dexeus campus link web
Aguaur link web